To develop the model of spontaneous DLBCL in dogs for molecular imaging and RIT, we isolated seven mouse monoclonal antibodies directed against the canine CD22 (CD22c) antigen. The gene discussed is CD22; the disease is diffuse large B-cell lymphoma.